1
2
1
2
3
4
5
6
7
8
9
10
11
12

We use cookies

Moalem Weitemeyer uses cookies, including cookies from third parties, needed to make the website work and to enhance the user experience. Cookies are also used to detect inexpediencies and to examine your interactions with our website. Read more about how we use cookies and take care of your data here

Necessary/functional

Statistical

Accept

4 May 2026

Moalem Weitemeyer advises Bpifrance in connection with its participation in Adcendo’s USD 75m Series C financing

Moalem Weitemeyer has advised Bpifrance in connection with its participation in Adcendo’s oversubscribed USD 75 million Series C financing round, led by Jeito Capital and supported by a strong syndicate of new and existing investors.

Adcendo is a Copenhagen-based clinical-stage biotech company developing first- and best-in-class antibody-drug conjugates targeting cancers with high unmet medical need. 

Bpifrance is a French public investment bank, supporting companies from early-stage venture through to large-cap growth and international expansion. 

Moalem Weitemeyer acted as Danish legal counsel to Bpifrance together with Dentons, who acted as lead counsel on the transaction. 

Poul Guo (Quach)/郭保罗

Head of Corporate M&A | Partner | LL.M. (Peking University)

+45 30 37 96 23

Go to profile

Pernille Nørkær

Partner

+45 30 37 96 40

Go to profile

Kadir Kurt

Senior Associate

+45 30 37 96 27

Go to profile